Neumora Therapeutics, Inc. Common StockNMRANASDAQ
Loading
Cash on hand plus short-term liquid investments
3Y CAGR
-29.7%/yr
Annual compound
Percentile
P20
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $142.15M | -62.0% |
| 2023 | $374.04M | +55.2% |
| 2022 | $240.94M | -41.1% |
| 2021 | $409.25M | +113.2% |
| 2020 | $191.98M | - |
| 2019 | $0.00 | - |